Annals of Hematology

, Volume 85, Issue 2, pp 132–133 | Cite as

Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib

  • J. Grassinger
  • T. Südhoff
  • R. Andreesen
  • B. Hennemann
Letter to the Editor

References

  1. 1.
    Kyle RA, Maldonado JE, Bayrd ED (1974) Plasma cell leukemia. Report on 17 cases. Arch Intern Med 133:813–818CrossRefPubMedGoogle Scholar
  2. 2.
    Bernasconi C, Castelli G, Pagnucco G, Brusamolino E (1989) Plasma cell leukemia: a report on 15 patients. Eur J Haematol Suppl 51:76–83PubMedGoogle Scholar
  3. 3.
    Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102:1115–1123CrossRefPubMedGoogle Scholar
  4. 4.
    Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609–2617CrossRefPubMedGoogle Scholar
  5. 5.
    Jagannath S, Barlogie B, Berenson J, Siegel D, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Adams J, Kauffman M, Esseltine DL, Schenkein DP, Anderson KC (2004) A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol 127:165–172CrossRefPubMedGoogle Scholar
  6. 6.
    Esparis-Ogando A, Alegre A, Aguado B, Mateo G, Gutierrez N, Blade J, Schenkein D, Pandiella A, San Miguel JF (2005) Bortezomib is an efficient agent in plasma cell leukemias. Int J Cancer 114:665–667CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • J. Grassinger
    • 1
  • T. Südhoff
    • 1
  • R. Andreesen
    • 2
  • B. Hennemann
    • 1
  1. 1.Department of Hematology and OncologyUniversity of RegensburgRegensburgGermany
  2. 2.Department of Hematology and OncologyKlinikum PassauPassauGermany

Personalised recommendations